CervoMed Inc. (CRVO) › Total LiabilitiesCervoMed Inc. (CRVO) — Total LiabilitiesAnnual figures by period end, from SEC filings.2010-12-31: $5.56M2011-12-31: $3.79M2013-12-31: $11.88M2014-12-31: $4.61M2015-12-31: $2.32M2016-12-31: $8.30M2017-12-31: $4.92M2018-12-31: $2.59M2019-12-31: $3.98M2020-12-31: $2.92M2021-12-31: $2.93M2022-12-31: $13.16M2023-12-31: $2.60M2024-12-31: $3.88M2025-12-31: $4.66M$4.66M2010-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$4.66M+20.0%2026-03-13Balance as of period end2024-12-31$3.88M+49.4%2026-03-13Balance as of period end2023-12-31$2.60M-80.3%2025-03-17Balance as of period end2022-12-31$13.16M+349.4%2024-03-29Balance as of period end2021-12-31$2.93M+0.4%2023-03-24Balance as of period end2020-12-31$2.92M-26.7%2022-03-18Balance as of period end2019-12-31$3.98M+53.5%2021-03-17Balance as of period end2018-12-31$2.59M-47.3%2020-03-17Balance as of period end2017-12-31$4.92M-40.8%2019-03-19Balance as of period end2016-12-31$8.30M+258.0%2018-04-02Balance as of period end2015-12-31$2.32M-49.7%2017-03-31Balance as of period end2014-12-31$4.61M-61.2%2016-03-25Balance as of period end2013-12-31$11.88M—2015-04-03Balance as of period end2011-12-31$3.79M-31.8%2012-05-21Balance as of period end2010-12-31$5.56M—2012-05-21Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)